Cancer Communications | Home page

Cancer Communications | Home page

Cancer Communications

Affiliated with

• 
• 
• Cancer Communications is affiliated with Chinese Anti-Cancer Association and US Chinese Anti-Cancer Association.

Articles

• Recent
• Most accessed
• Collections

1. Long-lasting responses after discontinuation of nivolumab treatment for reasons other than tumor progression in patients with previously treated, advanced non-small cell lung cancer

   Authors:Hideharu Kimura, Tomoyuki Araya, Taro Yoneda, Hiroki Shirasaki, Koji Kurokawa, Tamami Sakai, Hayato Koba, Yuichi Tambo, Shingo Nishikawa, Takashi Sone and Kazuo Kasahara

   Content type:Letter to the Editor

   21 November 2019

2. Post-translational modification of Parkin and its research progress in cancer

   Authors:Dan Ding, Xiang Ao, Ying Liu, Yuan-Yong Wang, Hong-Ge Fa, Meng-Yu Wang, Yu-Qi He and Jian-Xun Wang

   Content type:Review

   21 November 2019

3. Interactions between cancer cells and bone microenvironment promote bone metastasis in prostate cancer

   Authors:Xiangyu Zhang

   Content type:Review

   21 November 2019

4. Minimally invasive surgery alone compared with intensity-modulated radiotherapy for primary stage I nasopharyngeal carcinoma

   Authors:You-Ping Liu, Xing Lv, Xiong Zou, Yi-Jun Hua, Rui You, Qi Yang, Le Xia, Shao-Yan Guo, Wen Hu, Meng-Xia Zhang, Si-Yuan Chen, Mei Lin, Yu-Long Xie, Li-Zhi Liu, Rui Sun, Pei-Yu Huang…

   Content type:Original article

   15 November 2019

5. Tumor mutational burden as a new biomarker for PD-1 antibody treatment in gastric cancer

   Authors:Gunnar Folprecht

   Content type:Research highlight

   14 November 2019